This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Tracking of Normal and Malignant Progenitor Cell Cycle Transit in a Defined Niche
Scientific Reports Open Access 04 April 2016
-
ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells
Journal of Experimental & Clinical Cancer Research Open Access 28 May 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Melo JV, Barnes DJ . Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007; 7: 441–453.
Bacher U, Haferlach T, Hiddemann W, Schnittger S, Kern W, Schoch C . Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression. Cancer Genet Cytogenet 2005; 157: 53–61.
Fabarius A, Haferlach C, Muller MC, Erben P, Lahaye T, Giehl M et al. Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure. Haematologica 2007; 92: 834–837.
Huang Q, Wu Y, Snyder DS, Chang KL, Slovak ML, Gaal KK et al. Clinical and pathologic analysis of 16 cases of relapsed chronic myeloid leukemia after stem cell transplantation. Am J Clin Pathol 2007; 128: 565–570.
Penserga ET, Skorski T . Fusion tyrosine kinases: a result and cause of genomic instability. Oncogene 2007; 26: 11–20.
Johansson B, Fioretos T, Mitelman F . Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 2002; 107: 76–94.
Preti HA, O'Brien S, Giralt S, Beran M, Pierce S, Kantarjian HM . Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients. Am J Med 1994; 97: 60–65.
Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Martinez R, Wasik MA et al. Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase. Proc Natl Acad Sci USA 1996; 93: 13137–13142.
Dash AB, Williams IR, Kutok JL, Tomasson MH, Anastasiadou E, Lindahl K et al. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9. Proc Natl Acad Sci USA 2002; 99: 7622–7627.
Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H et al. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 1994; 13: 504–510.
Papadopoulos PC, Greenstein AM, Gaffney RA, Westbrook CA, Wiedemann LM . Characterization of the translocation breakpoint sequences in Philadelphia-positive acute lymphoblastic leukemia. Genes Chromosomes Cancer 1990; 1: 233–239.
Nowicki MO, Falinski R, Koptyra M, Slupianek A, Stoklosa T, Gloc E et al. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 2004; 104: 3746–3753.
Slupianek A, Nowicki MO, Koptyra M, Skorski T . BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells. DNA Repair (Amst) 2006; 5: 243–250.
Brady N, Gaymes TJ, Cheung M, Mufti GJ, Rassool FV . Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins. Cancer Res 2003; 63: 1798–1805.
Nieborowska-Skorska M, Stoklosa T, Datta M, Czechowska A, Rink L, Slupianek A et al. ATR-Chk1 axis protects BCR/ABL leukemia cells from the lethal effect of DNA double-strand breaks. Cell Cycle 2006; 5: 994–1000.
Gaymes TJ, Mufti GJ, Rassool FV . Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer. Cancer Res 2002; 62: 2791–2797.
Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO et al. BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell 2001; 8: 795–806.
Jabbour E, Kantarjian HM, Abruzzo LV, O'Brien S, Garcia-Manero G, Verstovsek S et al. Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood 2007; 110: 2991–2995.
Deininger MW, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M et al. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells. Cancer 2007; 110: 1509–1519.
Koptyra M, Falinski R, Nowicki MO, Stoklosa T, Majsterek I, Nieborowska-Skorska M et al. BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood 2006; 108: 319–327.
Libura J, Slater DJ, Felix CA, Richardson C . Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion. Blood 2005; 105: 2124–2131.
Neering SJ, Bushnell T, Sozer S, Ashton J, Rossi RM, Wang PY et al. Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood 2007; 110: 2578–2585.
Deutsch E, Dugray A, Karim B, Marangoni E, Maggiorella L, Vaganay S et al. BCR-ABL down-regulates the DNA repair protein DNA-PKcs. Blood 2001; 97: 2084–2090.
Richardson C, Stark JM, Ommundsen M, Jasin M . Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability. Oncogene 2004; 23: 546–553.
Peng Y, Zhang Q, Nagasawa H, Okayasu R, Liber HL, Bedford JS . Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res 2002; 62: 6400–6404.
Acknowledgements
This work was supported by the grants from the Department of Defense W81XWH-05-1-0214 (to T Skorski), and NCI R01CA100159-4 and the Stewart Trust Foundation (to C Richardson).
Author information
Authors and Affiliations
Corresponding author
Additional information
Note added in proof
Dr Martin Carroll (University of Pennsylvania, Philadelphia, PA, USA) submitted the manuscript indicating that BCR/ABL induces chromosomal aberrations after genotoxic stress.
Rights and permissions
About this article
Cite this article
Koptyra, M., Cramer, K., Slupianek, A. et al. BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress. Leukemia 22, 1969–1972 (2008). https://doi.org/10.1038/leu.2008.78
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2008.78
This article is cited by
-
Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia
Leukemia (2020)
-
Tracking of Normal and Malignant Progenitor Cell Cycle Transit in a Defined Niche
Scientific Reports (2016)
-
ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells
Journal of Experimental & Clinical Cancer Research (2015)
-
Natural course and biology of CML
Annals of Hematology (2015)
-
BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability
Leukemia (2013)